These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 5741565)

  • 41. [Niflumic acid in cervicofacial pathology].
    Gaillard J; Quilichini H
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1971 Nov; 20(9):1098-102. PubMed ID: 4257538
    [No Abstract]   [Full Text] [Related]  

  • 42. [Mechanism of action of a new anti-inflammatory analgesic drug in some eye disorders].
    Manusia M
    Minerva Oftalmol; 1967; 9(4):137-9. PubMed ID: 9082246
    [No Abstract]   [Full Text] [Related]  

  • 43. [Esfar in an ENT department].
    Traissac L; Pasquet J
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):177-9. PubMed ID: 1034331
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of oxyphenbutazone in pediatrics].
    Rosenberg D
    J Med Lyon; 1971 Jan; 52(201):117-22. PubMed ID: 5128927
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of a new antalgic anti-inflammatory agent in otorhinolaryngology].
    Portmann M; Pardes P
    Rev Laryngol Otol Rhinol (Bord); 1971; 92(3):235-8. PubMed ID: 5565287
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic note: the use of Alphamucase per os in ORL pathology].
    Mounier-Kuhn P; Haguenauer JP; Charachon R
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1967 Jan; 16(1):43-7. PubMed ID: 4229647
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hexahydropyrazine salt of phenylbutazone in O.R.L].
    Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1970 Jun; 87(6):397-402. PubMed ID: 5424469
    [No Abstract]   [Full Text] [Related]  

  • 48. [Study of Elarzone-Dausse, a new E.N.T. anti-inflammatory agent].
    Ammar-Khodja A
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):665-6 passim. PubMed ID: 4280432
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic and clinicopharmacological observations with oxyphenbutazone (Tanderil) and other anti-inflammatory agents of the pyrazolone group].
    Schmid E; Heinkel K; Jansen W; Meythaler C; Schäffer S; Tauber O
    Med Welt; 1967 Jan; 4():227-31. PubMed ID: 5300116
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study of a biological response modifier in the treatment of infections of the ORL region].
    Hötzinger H
    Acta Otorrinolaringol Esp; 1988; 39(2):135-8. PubMed ID: 3273773
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of inflammatory adnexal diseases of women with Irgapyrin].
    Silomon R
    Med Welt; 1969 Nov; 48():2649-51. PubMed ID: 5386516
    [No Abstract]   [Full Text] [Related]  

  • 52. [Controlled clinical and experimental researches on the niflumic acid action in odontostomatology].
    De Fazio M; De Fazio A
    Minerva Stomatol; 1972; 21(4):164-72. PubMed ID: 4570158
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical considerations on the topical use of benzidamine hydrochloride].
    Porchia I
    Valsalva; 1970 Aug; 46(4):176-90. PubMed ID: 5280147
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of an anti--inflammatory agent derived from pyrazolidine in the treatment of mumps].
    Camier P
    Lille Med; 1969 Feb; 14(2):Suppl 1:88-92. PubMed ID: 5405150
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical application of Apoplectal (drug affecting the peripheral circulation) in otorhinologic field].
    Mishima A
    Jibiinkoka; 1971 Mar; 43(3):257-62. PubMed ID: 5102070
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical observations on the anti-inflammatory activity of the association of benzydamine and tetracycline].
    Cairella M; Volpari B
    Clin Ter; 1969 Dec; 51(5):439-51. PubMed ID: 5382105
    [No Abstract]   [Full Text] [Related]  

  • 57. Double-blind clinical trial of protacine versus oxyphenbutazone in rheumatic disorders.
    Loizzi P; Pipitone V; Bignamini AA
    Pharmatherapeutica; 1980; 2(5):285-92. PubMed ID: 7001487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Our experience with thiamphenicol in otorhinolaryngology].
    Philip F
    Rev Laryngol Otol Rhinol (Bord); 1970; 91(7):620-4. PubMed ID: 5526589
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic evaluation of a new pyrazolone derivative (Aminopropilon) in articular and muscular painful symptoms].
    Dell'Orto R
    Minerva Ortop; 1970 Feb; 21(2):151-5. PubMed ID: 5446173
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical study of an antihistamine administered in delayed action form: dimegan].
    Mounier-Kuhn P; Haguenauer JP
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1968 May; 17(5):456-7. PubMed ID: 4386661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.